跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
PMS-PERINDOPRIL-AMLODIPINE
Authorized
STANDARD
PMS-PERINDOPRIL-AMLODIPINE
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
81d238453ffae7fb
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
81d238453ffae7fb
Drug Approval Canada Name
PMS-PERINDOPRIL-AMLODIPINE
Product Name
PMS-PERINDOPRIL-AMLODIPINE
Status
Marketed
Status Date
2024-02-21
Original Market Date
2024-02-21
Din
02541696
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09BB04 PERINDOPRIL AND AMLODIPINE
Atc Name
c 09 bb 04
Aig Number
0257790001
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
PERINDOPRIL ARGININE
3.5 MG
AMLODIPINE (AMLODIPINE BESYLATE)
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
81d238453ffae7fb
Type
Standard
Back to Health Canada Approvals
PMS-PERINDOPRIL-AMLODIPINE - Health Canada Drug Approval Details